Natural Biomaterials Market – Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Natural Biomaterials Market – Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Biomaterials are regarded as non-drug material, which is used for enhancing or replacing and treating any tissue, organ or function in an organism. The definition of biomaterial was reframed as a non-drug substance, which is suitable for inclusions in systems, replacing or augmenting the function of body tissue or organ. This materials can be synthetic or natural, non-living or living, and are made of multiple components that interact with biological system. They are compatible to be used in place of living tissues in organisms.
Biomaterials are widely used in drug delivery and are biodegradable so that they can disappear from organism after the completion of their function. These can be used in medical applications as replacement to bones, cartilage regeneration during an orthopedic surgery, collagen membrane and regenerative dentistry.
Market Dynamics
On the basis of application, cardiovascular segment held dominant position in the global natural biomaterials market and contributed 35.0% in 2021, in terms of revenue. The rising number of heart surgeries and implants coupled with growing investment in the field of cardiovascular biomaterials (CB) is expected to propel demand for natural biomaterials in the near future. However, plastic surgery and wound healing is predicted to record fastest growth over the forecast period (2019 to 2027).
Furthermore, wound healing and plastic surgery is expected to be the high growth applications. Rising demand for minimal invasive cosmetic and plastic surgeries due to positive public perception about these surgeries from emerging economies such as China and India along with growing government support is anticipated to boost the demand for natural biomaterials over the forecast period.
Key features of the study:
This report provides in-depth analysis of natural biomaterials and provides market size (US$ Billion) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global natural biomaterials market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include BASF SE, Biomet, Inc., Invibio Ltd., Mimetis Biomaterials, Royal DSM, Corbion N.V., Botiss Biomaterials GmbH, and Medtronic, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future products launches, technology up-gradation, market expansion, and marketing tactics
The global natural biomaterials market report caters to various stakeholders in this industry including investors, suppliers, natural biomaterials manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the natural biomaterials market
Detailed Segmentation:
Global Natural biomaterials Market, By Product Type:
Hyaluronic Acid
Collagen
Gelatin
Fibrin
Cellulose
Chitin/chitosan
Others (Alginate, Silk, etc.)
Global Natural biomaterials Market, By Application:
Cardiovascular
Orthopedic
Dental
Plastic Surgery
Wound Healing
Neurology
Neurological Disorders/Central Nervous Systems
Tissue Engineering
Ophthalmology
Others (Drug Delivery Systems, Gastrointestinal Application, Bariatric Surgery, Urinary Applications, etc.)
Global Natural biomaterials Market, By Geography:
North America
U.S.
By Product Type:
Hyaluronic Acid
Collagen
Gelatin
Fibrin
Cellulose
Chitin/chitosan
Others
By Application:
Cardiovascular
Orthopedic
Dental
Plastic Surgery
Wound Healing
Neurology
Neurological Disorders/Central Nervous Systems
Tissue Engineering
Ophthalmology
Others
Canada
By Product Type:
Hyaluronic Acid
Collagen
Gelatin
Fibrin
Cellulose
Chitin/chitosan
Others
By Application:
Cardiovascular
Orthopedic
Dental
Plastic Surgery
Wound Healing
Neurology
Neurological Disorders/Central Nervous Systems
Tissue Engineering
Ophthalmology
Others
Europe
U.K.
By Product Type:
Hyaluronic Acid
Collagen
Gelatin
Fibrin
Cellulose
Chitin/chitosan
Others
By Application:
Cardiovascular
Orthopedic
Dental
Plastic Surgery
Wound Healing
Neurology
Neurological Disorders/Central Nervous Systems
Tissue Engineering
Ophthalmology
Others
Germany
By Product Type:
Hyaluronic Acid
Collagen
Gelatin
Fibrin
Cellulose
Chitin/chitosan
Others
By Application:
Cardiovascular
Orthopedic
Dental
Plastic Surgery
Wound Healing
Neurology
Neurological Disorders/Central Nervous Systems
Tissue Engineering
Ophthalmology
Others
Italy
By Product Type:
Hyaluronic Acid
Collagen
Gelatin
Fibrin
Cellulose
Chitin/chitosan
Others
By Application:
Cardiovascular
Orthopedic
Dental
Plastic Surgery
Wound Healing
Neurology
Neurological Disorders/Central Nervous Systems
Tissue Engineering
Ophthalmology
Others
France
By Product Type:
Hyaluronic Acid
Collagen
Gelatin
Fibrin
Cellulose
Chitin/chitosan
Others
By Application:
Cardiovascular
Orthopedic
Dental
Plastic Surgery
Wound Healing
Neurology
Neurological Disorders/Central Nervous Systems
Tissue Engineering
Ophthalmology
Others
Spain
By Product Type:
Hyaluronic Acid
Collagen
Gelatin
Fibrin
Cellulose
Chitin/chitosan
Others
By Application:
Cardiovascular
Orthopedic
Dental
Plastic Surgery
Wound Healing
Neurology
Neurological Disorders/Central Nervous Systems
Tissue Engineering
Ophthalmology
Others
Rest of Europe
By Product Type:
Hyaluronic Acid
Collagen
Gelatin
Fibrin
Cellulose
Chitin/chitosan
Others
By Application:
Cardiovascular
Orthopedic
Dental
Plastic Surgery
Wound Healing
Neurology
Neurological Disorders/Central Nervous Systems
Tissue Engineering
Ophthalmology
Others
Asia Pacific
China
By Product Type:
Hyaluronic Acid
Collagen
Gelatin
Fibrin
Cellulose
Chitin/chitosan
Others
By Application:
Cardiovascular
Orthopedic
Dental
Plastic Surgery
Wound Healing
Neurology
Neurological Disorders/Central Nervous Systems
Tissue Engineering
Ophthalmology
Others
India
By Product Type:
Hyaluronic Acid
Collagen
Gelatin
Fibrin
Cellulose
Chitin/chitosan
Others
By Application:
Cardiovascular
Orthopedic
Dental
Plastic Surgery
Wound Healing
Neurology
Neurological Disorders/Central Nervous Systems
Tissue Engineering
Ophthalmology
Others
Japan
By Product Type:
Hyaluronic Acid
Collagen
Gelatin
Fibrin
Cellulose
Chitin/chitosan
Others
By Application:
Cardiovascular
Orthopedic
Dental
Plastic Surgery
Wound Healing
Neurology
Neurological Disorders/Central Nervous Systems
Tissue Engineering
Ophthalmology
Others
Australia
By Product Type:
Hyaluronic Acid
Collagen
Gelatin
Fibrin
Cellulose
Chitin/chitosan
Others
By Application:
Cardiovascular
Orthopedic
Dental
Plastic Surgery
Wound Healing
Neurology
Neurological Disorders/Central Nervous Systems
Tissue Engineering
Ophthalmology
Others
South Korea
By Product Type:
Hyaluronic Acid
Collagen
Gelatin
Fibrin
Cellulose
Chitin/chitosan
Others
By Application:
Cardiovascular
Orthopedic
Dental
Plastic Surgery
Wound Healing
Neurology
Neurological Disorders/Central Nervous Systems
Tissue Engineering
Ophthalmology
Others
Rest of Asia Pacific
By Product Type:
Hyaluronic Acid
Collagen
Gelatin
Fibrin
Cellulose
Chitin/chitosan
Others
By Application:
Cardiovascular
Orthopedic
Dental
Plastic Surgery
Wound Healing
Neurology
Neurological Disorders/Central Nervous Systems
Tissue Engineering
Ophthalmology
Others
Latin America
Brazil
By Product Type:
Hyaluronic Acid
Collagen
Gelatin
Fibrin
Cellulose
Chitin/chitosan
Others
By Application:
Cardiovascular
Orthopedic
Dental
Plastic Surgery
Wound Healing
Neurology
Neurological Disorders/Central Nervous Systems
Tissue Engineering
Ophthalmology
Others
Mexico
By Product Type:
Hyaluronic Acid
Collagen
Gelatin
Fibrin
Cellulose
Chitin/chitosan
Others
By Application:
Cardiovascular
Orthopedic
Dental
Plastic Surgery
Wound Healing
Neurology
Neurological Disorders/Central Nervous Systems
Tissue Engineering
Ophthalmology
Others
Argentina
By Product Type:
Hyaluronic Acid
Collagen
Gelatin
Fibrin
Cellulose
Chitin/chitosan
Others
By Application:
Cardiovascular
Orthopedic
Dental
Plastic Surgery
Wound Healing
Neurology
Neurological Disorders/Central Nervous Systems
Tissue Engineering
Ophthalmology
Others
Rest of Latin America
By Product Type:
Hyaluronic Acid
Collagen
Gelatin
Fibrin
Cellulose
Chitin/chitosan
Others
By Application:
Cardiovascular
Orthopedic
Dental
Plastic Surgery
Wound Healing
Neurology
Neurological Disorders/Central Nervous Systems
Tissue Engineering
Ophthalmology
Others
Middle East & Africa
Middle East
By Product Type:
Hyaluronic Acid
Collagen
Gelatin
Fibrin
Cellulose
Chitin/chitosan
Others
By Application:
Cardiovascular
Orthopedic
Dental
Plastic Surgery
Wound Healing
Neurology
Neurological Disorders/Central Nervous Systems
Tissue Engineering
Ophthalmology
Others
Africa
By Product Type:
Hyaluronic Acid
Collagen
Gelatin
Fibrin
Cellulose
Chitin/chitosan
Others
By Application:
Cardiovascular
Orthopedic
Dental
Plastic Surgery
Wound Healing
Neurology
Neurological Disorders/Central Nervous Systems
Tissue Engineering
Ophthalmology
Others
Company Profiles
BASF SE
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Biomet, Inc.
Berkeley Advanced Biomaterials, Inc. (BAB)
DSM Biomedical
Evonik Industries AG
Bayer AG
Invibio Ltd.
Botiss Biomaterials GmbH
Medtronic, Inc.
“*” marked represents similar segmentation in other categories in the respective section.